top of page
This site was designed with the
.com
website builder. Create your website today.Start Now

NEWS

Biotechnology, Drug Discovery, CNS and Rare Disease, Life Science Industry

DNA Strand

CELLECTIS GETS FDA PASS TO CONTINUE ITS CLINICAL TRIAL OF THE NOVEL CAR-T CELL THERAPY

November 6, 2017

Embryonic Stem Cells

NOVARTIS SEEKS LYMPHOMA MARKET FOR THEIR CAR-T CELL THERAPY

November 2, 2017

cells-1872666.jpg

FDA APPROVED KITE'S YESCARTA FOR NON-HODGKIN LYMPHOMA; GILEAD SHARE ROSE

October 18, 2017

DNA

BLUEBIRD'S GENE THERAPY SHOWED PROMISE FOR LORENZO'S OIL DISEASE

Oct 6, 2017

bottom of page